These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3132582)

  • 1. 31P NMR studies of the diabetic lens.
    González RG; Miglior S; Von Saltza I; Buckley L; Neuringer LJ; Cheng HM
    Magn Reson Med; 1988 Apr; 6(4):435-44. PubMed ID: 3132582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic rats.
    Gonzalez AM; Sochor M; McLean P
    Diabetes; 1983 May; 32(5):482-5. PubMed ID: 6404681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of insulin and aldose reductase inhibition on the phosphate metabolism of streptozotocin-diabetic rat lens.
    Cheng HM; Yoshida A; Xiong H; González RG
    Exp Eye Res; 1991 Dec; 53(6):805-8. PubMed ID: 1783017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of an aldose reductase inhibitor on lens phosphorylcholine under hyperglycemic conditions: biochemical and NMR studies.
    Lou MF; Garadi R; Thomas DM; Mahendroo PP; York BM; Jernigan HM
    Exp Eye Res; 1989 Jan; 48(1):11-24. PubMed ID: 2493385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase inhibition and the phosphorus-31 profile of the intact diabetic rat lens.
    Tsubota K; Yoshida M; Toda T; Ono M; Kajiwara K; Cheng HM
    Ophthalmic Res; 1993; 25(6):393-9. PubMed ID: 8309679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The increase in lipid peroxidation in diabetic rat lens can be reversed by oral sorbinil.
    Yeh LA; Ashton MA
    Metabolism; 1990 Jun; 39(6):619-22. PubMed ID: 2112676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H; Yaginuma T; Mizuno A
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
    [No Abstract]   [Full Text] [Related]  

  • 8. The utilization of 13C and 31P nuclear magnetic resonance spectroscopy in the study of the sorbitol pathway and aldose reductase inhibition in intact rabbit lenses.
    Williams WF; Odom JD
    Exp Eye Res; 1987 Jun; 44(6):717-30. PubMed ID: 3115803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
    Gonzalez AM; Sochor M; Hothersall JS; McLean P
    Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered phosphate metabolism in the intact rabbit lens under high glucose conditions and its prevention by an aldose reductase inhibitor.
    González RG; Barnett P; Cheng HM; Chylack LT
    Exp Eye Res; 1984 Nov; 39(5):553-62. PubMed ID: 6440802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
    Cheng HM; González RG
    Metabolism; 1986 Apr; 35(4 Suppl 1):10-4. PubMed ID: 3083198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H; Nozawa Y; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
    Obrosova IG; Fathallah L
    Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fructose-3-phosphate production and polyol pathway metabolism in diabetic rat hearts.
    Lal S; Randall WC; Taylor AH; Kappler F; Walker M; Brown TR; Szwergold BS
    Metabolism; 1997 Nov; 46(11):1333-8. PubMed ID: 9361695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats.
    Yeh LA; Rafford CE; Goddu KJ; Ashton MA; Beyer TA; Hutson NJ
    Diabetes; 1987 Dec; 36(12):1414-9. PubMed ID: 2824260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors].
    Brogard JM; Caro-Sampara F; Blicklé JF
    Rev Med Interne; 1992; 13(1):69-79. PubMed ID: 1410879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione redox state is not the link between polyol pathway activity and myo-inositol-related Na+-K+-ATPase defect in experimental diabetic neuropathy.
    Carroll PB; Thornton BM; Greene DA
    Diabetes; 1986 Nov; 35(11):1282-5. PubMed ID: 3019809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.